RetinaCME
VIDEOCMEABO MOC

Curbside Consults on Retinal Vein Occlusion Management: Deciphering New Data on RVO Treatment – How Do they Affect Real-World Practice?

Author(s)/Faculty: Carl D. Regillo, MD, FACS; David Eichenbaum, MD
Release Date: 5/31/2021Expiration Date: 5/30/2022
Credit Type: CME / CME with ABO Continuing Certification Number of Credits: 0.25
Content Type: VideoProvider:
Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden. In this curbside consult, Drs. Carl Regillo and David Eichenbaum discuss how advances in the treatment of RVO achieved in clinical trials can be applied to real-world practice.